Government Health The Sciences DCGI Approves Virafin for Moderate COVID. Where’s the Evidence It Works? Ronak Borana 24/04/2021 0 Virafin's phase 2 trial has several methodological and reporting...Read More
Health The Sciences Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress Dr Jammi Nagaraj Rao 06/12/2020 0 The researchers who conducted the inadequate trial on itolizumab...Read More
